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Abstract
Background: Helicobacter pylori diagnosis and susceptibility profile directs the applicability of
recommended treatment regimens in our setting. To our knowledge, there is no published data on
the culture and local susceptibility pattern of Helicobacter pylori in the Philippines.
Methods:  52 dyspeptic adult patients undergoing endoscopy from the Outpatient
Gastroenterology clinic of the University of the Philippines-Philippine General Hospital underwent
multiple gastric biopsy and specimens were submitted for gram stain, culture, antimicrobial
sensitivity testing, rapid urease test and histology. Antimicrobial susceptibility testing was done by
Epsilometer testing (Etest) method against metronidazole, clarithromycin, amoxicillin, and
tetracycline.
Results: Sixty percent (60%) of the study population was positive for H. pylori infection (mean age
of 44 years ± 13), 70% were males. H. pylori culture showed a sensitivity of 45% (95% CI [29.5–
62.1]), specificity of 98% (95%CI [81.5–100%]), positive likelihood ratio of 19.93 (95% CI [1.254–
317.04]) and a negative likelihood ratio of 0.56 (95% CI [0.406–0.772]). All H. pylori strains isolated
were sensitive to metronidazole, clarithromycin, amoxicillin and tetracycline.
Conclusion: Knowledge of the antibiotic susceptibility patterns in our setting allows us to be more
cautious in the choice of first-line agents. Information on antibiotic susceptibility profile plays an
important role in empiric antibiotic treatment and management of refractive cases.
Background
Helicobacter pylori is a gram-negative bacterium that colo-
nizes the gastric mucosa of more than half of the world's
population [1,2] Since its isolation in 1982, the associa-
tion between H. pylori infection and the subsequent devel-
opment of chronic active gastritis, peptic ulcer disease,
gastric cell carcinoma and B cell MALT lymphoma has
been well established[3]. The principal reservoir of
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infection is the human stomach and transmission has
been epidemiologically linked to person to person contact
[4]. The prevalence of infection is greater in developing
countries and is influenced by socioeconomic conditions,
ethnic background and age[5,6] In the Philippines, there
is scarcity of published data regarding the epidemiology
of this bacterium. Locally unpublished reports revealed a
prevalence of 5.6% seropositivity rate in children and
60% among 136 adult Filipino patients with dyspepsia
using the Clotest® (Cabahug et. al. 2003 and Caballero et
al., 1997, unpublished data). A lower prevalence rate of
42% was reported by Daez et. al. in 2002 (unpublished
data) among 375 patients undergoing endoscopy at the
Philippine General Hospital utilizing the rapid urease test
and histopathology.
Microbiological isolation of the organism is the theoreti-
cal gold standard for the detection of H. pylori infections.
However, isolation of the organism by culture has been
highly variable. Success rates depend on the technical
expertise of the microbiology laboratory, ranging from
30% to 73%[7,8]. Failure to detect the organism may be
due to sampling error, inappropriate transport or culture
media and insufficient incubation period.
In clinical practice, gastric biopsy with culture is not rou-
tinely performed due to the availability of more rapid
diagnostic tests in the detection of H. pylori such as urease
broth tests, urea breath tests, serologic methods and stool
antigen detection. However, the increasing prevalence of
resistant strains makes culture and antibiotic sensitivity
testing valuable to determine alternative treatment regi-
mens after failure of initial eradication regimen.
In the Philippines, due to methodological difficulties in
isolating the organism, detection of the organism by cul-
ture methods has not been popular. Realizing the increas-
ing prevalence of antimicrobial resistance in other
countries and its potential negative impact on the efficacy
of many treatment eradication regimens, it is important in
clinical practice to determine the prevailing local antibi-
otic susceptibility patterns when choosing appropriate
eradication regimens for H. pylori infections in the empiric
setting.
This study aims to evaluate the use of culture in the diag-
nosis of H. pylori infection among patients with dyspepsia,
to determine the sensitivity and specificity of culture tech-
nique in the detection of H. pylori infection, and to deter-
mine the antibiotic susceptibility patterns of H. pylori
organisms isolated by culture among Filipino patients.
Methods
This is a prospective, cross-sectional study involving adult
patients with dyspepsia, who had independently been
determined to have clinical indications for an endoscopy
at the out-patient gastrointestinal clinic of the Philippine
General Hospital, a tertiary training university hospital in
Manila. Eligible patients were enrolled in the study after
informed consent to undergo the required diagnostic test-
ing of endoscopy samples.
Patients were excluded if they were less than 18 years old,
had a history of proton pump inhibitors (PPI) intake
within 2 weeks, H2 antagonists within 1 week and antibi-
otic intake within 1 month prior to inclusion in the study.
The nature and purpose of the study were discussed with
the patient until fully understood. All patients with dys-
pepsia undergoing endoscopy who fulfilled the inclusion
criteria had a complete history and physical examination.
Data were obtained using a data collection form. Partici-
pants underwent upper gut endoscopy as clinically indi-
cated. Pre-procedure preparations for
Esophagogastroduodenoscopy were performed according
to standard methods. Biopsy of gastric tissue were col-
lected from the antrum and body of the stomach and
specimens were sent for (1) histopathologic study, (2)
gram staining, (3) culture and sensitivity and (4) rapid
urease broth test. Those interpreting results of the above
diagnostic tests were blinded.
Case Definition
A patient with Helicobacter pylori infection was defined as
those patients independently assessed by their attending
physician based on clinical symptoms and a positive test
for any of the two diagnostic tests (histology and rapid
urease test). In the evaluation of the diagnostic perform-
ance of H. pylori culture, the above clinico-laboratory case
definition were used as the comparator reference
standard.
Description of the Diagnostic Tests
Gram stain and Culture
Two pieces of gastric tissue were obtained and placed in
0.2 mL sterile saline and transported to the microbiology
laboratory for processing. The biopsy specimen was
placed in a sterile petri dish and minced with 2 sterile scal-
pel blades. Specimens were inoculated in both 7% Horse
Blood + Brain Heart Infusion Agar (HBAP) and Brucella
Blood Agar with Skirrow's supplement (5% defibrinated
Sheep's Blood with Trimethoprim (5 mg/L), Vancomycin
10 mg/L and Polymixin B (2500 units/L))[9] Plates were
incubated at 37°C for 7–10 days in a microaerophilic
incubation environment and examined every other day
(Pack-Microaero, Mitsubishi gas co., Japan). H. pylori col-
onies are typically small, flat and translucent to grey. On
days 4 to 5, all plates with no characteristic colonies, were
subcultured to a fresh HBAP to promote growth of slow or
fastidious strains and incubated for an additional 3 to 5Annals of Clinical Microbiology and Antimicrobials 2004, 3:25 http://www.ann-clinmicrob.com/content/3/1/25
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days. Plates were examined until the tenth day before
reporting a negative growth. Suspected H. pylori colonies
were tested for urease, oxidase and catalase production. A
modified gram stain was performed on a methanol-fixed
smear using crystal violet for 1 minute followed by a water
wash and then a safranin counter stain for 30 minutes
prior to a final washing with tap water The smear was air-
dried and examined under oil immersion.
The presence of H. pylori is confirmed by the presence of a
gram negative curved bacilli and a positive test for urease,
oxidase and catalase production. Five H. pylori isolates
that survived the shipping and handling were verified at
University of Virginia Center for Studies of Diseases Due
to H. pylori.
Sensitivity Study
Epsilometer test (Etest, AB Biodisk, USA) was used to
determine the minimal inhibitory concentrations (MIC).
MIC values were read as the intercept of the elliptical zone
of inhibition with the graded strip for the Etest. Strains
were considered resistant when the MIC was >8 g/ml for
metronidazole, >1 g/ml for clarithromycin and >0.5 g/ml
for amoxicillin. These breakpoints were used based on the
recommendations from the National Committee for Clin-
ical Laboratory Standards (NCCLS) and a large clinical
trial [10,11]. For tetracycline, resistance was determined at
an MIC of >2 µg/ml based on a previous publica-
tions[12,13]. Sensitivity results were compared with a
standard susceptible strain of H. pylori (NCTC # 12822)
and the University of Virginia Center for Studies of Dis-
eases Due to H. pylori metronidazole resistant culture
strain #Cp 2124 and clarithromycin resistant strain #Cp
5535. In the absence of a resistant control for amoxicillin
and tetracycline, susceptibility breakpoints set by NCCLS
and large clinical trials were used[10,11,13].
Rapid Urease Test
The Rapid Urease Test (RUT) was performed by placing
0.5 ml of 8% (weight/vol) unbuffered urea in distilled
water (pH 6.8) in a clear 0.7 ml Eppendorf tube, to which
one drop of 1% phenol red (free acid) suspension was
added. The urea solutions was stored at 4°C and prepared
on the day of use to ensure color stability. Two gastric
biopsy specimens from the antrum and body were placed
in the tube. A positive test was indicated by a rapid color
change of the media surrounding the biopsy from yellow
to magenta followed by a rapid generalized color change
throughout the media. A negative result was indicated
when there was no change in color appreciated after 2
hours of observation.
Histopathologic Examination
Specimens were sent to the pathology lab and gastric tis-
sues were fixed and stained with Giemsa and Hematoxy-
lin-Eosin dye. A specimen was read as positive if curve
bacilli organisms were seen on microscopy. Pathologists
were blinded to the results of the other diagnostic tests.
Statistical Analysis
Demographic data was described using rates and percent-
ages for categorical variables. For continuous variables,
means and standard deviations were used. Measures of
accuracy for H. pylori culture were expressed as sensitivity
and specificity rates, positive and negative predictive val-
ues and likelihood ratios with a 95% confidence interval.
Results
Patient Characteristics
Among 52 patients with dyspepsia, 31 (60%) were posi-
tive for H. pylori infection based on the pre-defined case
definition. The mean age for H. pylori infected individuals
was 44 years ± 13. Seventy percent were males with a
male:female ratio of 2:1. The majority of infected patient
were married (80%), and had reached only up to the sec-
ondary level of education (70%). Fifty-five percent were
unemployed. Seventy-five percent of infected patients had
access to piped water. No significant differences among
the demographic characteristics of H. pylori positive and
negative cases were observed.
Laboratory Diagnosis of H. pylori
All included patients underwent the 3 diagnostic tests for
the diagnosis of H. pylori infection (histopathology, rapid
urease test (RUT) and culture) (figure 1). Fourteen of the
52 patients grew H. pylori on culture. Ten of the 14 posi-
tive culture samples were also positive for both histology
and RUT, 14 and 10 were positive for RUT and histology
alone, respectively. To validate the accuracy rate of H.
pylori culture, results of the culture studies were compared
with clinically defined cases of H. pylori infection, in this
case patients who presents with abdominal symptoms
and positive for at least one of the two diagnostic tests,
histopathology and RUT. H. pylori culture showed a sensi-
tivity of 45% (95% CI [29.5–62.1%]), specificity of 98%
(95%CI [81.5–99.8%]), positive likelihood ratio of 19.93
(95% CI [1.254–317.04]) and a negative likelihood ratio
of 0.56 (95% CI [0.406–0.772]). The positive predictive
value was 97% (95% CI [74.7–99.7%])) and the negative
predictive value was 55% (95% CI [39.8–69.7%]).
A total of 14 H. pylori organisms were isolated from 52
clinical specimens. The mean number of incubation time
was 3.8 days ± 1 day. All isolates grew on primary plates.
All isolates were highly sensitive to amoxicillin (mean
MIC of 0.016 ug/ml by Etest)), tetracycline (mean MIC of
0.164 ug/ml SD ± 0.16 SD by Etest), metronidazole
(mean MIC of 0.061 ug/ml SD ± 0.04 by Etest) and clari-
thromycin (mean MIC of 0.016 SD ± 0 by Etest) (table 1).Annals of Clinical Microbiology and Antimicrobials 2004, 3:25 http://www.ann-clinmicrob.com/content/3/1/25
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Discussion
This pilot study reported an H. pylori culture sensitivity
rate of 45% and a specificity rate of 98–100% which are
comparable to those reported in other countries[8,14-17].
High positive predictive values coupled with an interme-
diate to high likelihood ratio demonstrates that gastric tis-
sue culture is highly specific, making it a useful
confirmatory test in the diagnosis of H. pylori infection. Its
low sensitivity is acceptable since this method is not rec-
ommended as a screening test. This study also supported
previous studies that the rapid urease test whether in a gel
or liquid preparation is a highly sensitive tool which qual-
ifies as a good screening test among suspected H. pylori
infected individuals[13,18,19].
Antibiotic resistance has increasingly been recognized as a
major cause of treatment failure for H. pylori infection. Pri-
mary antimicrobial resistance against clarithromycin and
metronidazole is now commonplace in several coun-
tries[2,20-26]. Regional variations in susceptibility and
resistance patterns may be ascribed to differences in local
antibiotic prescription practices, antibiotic usage in the
community and mass eradication programs for H. pylori
infection as part of gastric cancer prevention strategies.
These factors may well be expected to influence success of
eradication therapy [27-29].
Table 1: Sensitivity study Helicobacter pylori isolates*
ISOLATE NO. AMOXICILLIN TETRACYCLINE METRONIDAZOLE CLARITHROMYCIN
*Etest Resistance Breakpoints
> 0.5 ug/ml > 2 ug/ml > 8 ug/ml > 1 ug/ml
1 0.016 0.032 0.016 0.016
2 0.016 0.19 0.125 0.016
3 0.016 0.016 0.016 0.016
4 0.016 0.38 0.064 0.016
5 0.016 0.38 0.064 0.016
6 0.016 0.19 0.125 0.016
7 0.016 0.032 0.016 0.016
8 0.016 0.38 0.016 0.016
9 0.016 0.032 0.064 0.016
10 0.016 0.19 0.016 0.016
11 0.016 0.38 0.016 0.016
12 0.016 0.032 0.125 0.016
13 0.016 0.032 0.064 0.016
14 0.016 0.032 0.125 0.016
Strain # CP2124§ 0.015 0.015 33 0.015
Strain # CP5535§ 0.015 0.125 1.5 257
* all Etest studies done on the Philippine isolates were in the sensitive ranges
§UVa (University of Virginia) Metronidazole resistant isolate
¥UVa Clarithromycin resistant isolate
Comparative positivity of diagnostic tests: RUT (rapid urease  test) and histology to H. pylori culture Figure 1
Comparative positivity of diagnostic tests: RUT 
(rapid urease test) and histology to H. pylori culture. 
All patients underwent biopsy, RUT and culture studies. 
Among the 31 clinico-laboratory defined cases, 14 were cul-
ture positive. Ten of the H. pylori culture positive cases were 
also positive for both histology and RUT. All 14 culture posi-
tive isolates tested positive for RUT while only 10 were pos-
itive for histology.Annals of Clinical Microbiology and Antimicrobials 2004, 3:25 http://www.ann-clinmicrob.com/content/3/1/25
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All 14 strains isolated showed sensitivity to all the first
line antibiotics namely metronidazole, amoxicillin, clari-
thromycin and tetracycline. No resistant strains were iso-
lated based on the Etest method. Susceptibility patterns in
Europe and the United States revealed that the highest
resistance is to metronidazole ranging from 33.1% to
36.9%. Clarithromycin resistance was observed to be 10%
in both areas. In contrast, Japanese data showed that clar-
ithromycin resistance was 29% closely followed by metro-
nidazole at 24%. Amoxicillin resistance remained low at
0–1.4% in all three geographic locations[3,21,23]. While
susceptibility studies were done on large numbers of iso-
lates in foreign data, this local study comprises one of the
pioneering attempts, to determine the antibiotic suscepti-
bility pattern of H. pylori infection in the Philippines.
Potential reasons for the absence of resistant H. pylori
strains in our pilot study point to the type of population
enrolled. Based on the selection criteria, these patients
had no exposure to previous antibiotic nor had previous
H. pylori eradication treatment, a strong risk factor for the
development of acquired resistance. Another possible
explanation for the low resistance of H. pylori isolates as
compared to other Asian countries, is the difficulty pro-
curing antibiotics due to their restrictive cost. In this
study, 70% of H. pylori positive patients were unemployed
with average incomes below the poverty level, defined as
income below the annual per capita poverty threshold of
PHP 18,000.00 for the National Capital Region of the
Philippines (2001 Philippine Health Situation, Depart-
ment of Health, Manila, Philippines, http://
www.doh.gov.ph). A study of the World Health Organiza-
tion's Programme for appropriate Health Care Technol-
ogy (ATH) has shown a correlation between the
occurrence of multi-resistant bacteria and antibiotic con-
sumption patterns. The Philippines has the highest per-
centage in 1983 of antibiotic utilization among countries
(including USA, Japan, United Kingdom) surveyed
(>25%). However, majority of the people whether rich or
poor allot minimum expenses for medical care at 2.7%
and 1.2%, respectively[30]. Such paradox in resistance
patterns may well be explained by the capacity of these
patients to actually afford the prescribed duration of anti-
biotic therapy. While many Filipinos may be (mis-)
guided on the appropriate choice of antibiotic therapy by
media or product representatives, the cost of these drugs
still limits the access to these largely economically disad-
vantaged group. Although the presence of primary resist-
ance of H. pylori has been well documented in other
studies, the absence of primary resistance in our results
may also be an underestimate of the true prevalence of H.
pylori resistance because of the smaller sample size com-
pared with published literature[2,20,25,26]. Only with
continued surveillance of susceptibility patterns and a
larger sample size of isolates will provide a more substan-
tial answer to the issue of resistance of H. pylori in the
Philippines.
Knowledge of the antibiotic susceptibility patterns in our
setting allows us to be more cautious in the choice of first-
line agents. The use of culture technique in the diagnosis
of H. pylori infection approximates that in published liter-
ature abroad. In the absence of standard disk diffusion
zone sizes for regimens used in H. pylori eradication regi-
men except for metronidazole, further establishment of
the susceptibility pattern of locally occurring isolates by
comparing zone size breakpoints with Etest, agar dilution
method and as well as molecular genotyping of resistant
strains will be the future direction of this pilot study.
Conclusions
While the use of culture is not an ideal test for the rapid
diagnosis of H. pylori infection, information on antibiotic
susceptibility profile plays an important role in empiric
antibiotic treatment and management of refractive cases
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